Related Experiment Videos
Use of hypoxia-directed drugs in the therapy of solid tumors
1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510-8040.
Abstract:
Solid tumors in experimental animals and human patients contain areas in which transient or persistent perfusion deficits lead to the development of hypoxia, low pH, and nutritional deprivation. These microenvironmental inadequacies induce resistance to ionizing radiation and to many antineoplastic drugs, but also offer mechanisms that can be used to target certain drugs to solid malignancies. Regimens incorporating hypoxia-directed drugs as adjuncts to radiotherapy or conventional chemotherapy can be used to increase the therapeutic ratio by increasing local tumor control without producing a concomitant increase in toxicities to normal tissues.
Insights
Solid tumors often have hypoxic and nutrient-deprived areas that resist treatment. Targeting these tumor microenvironments with specific drugs can improve cancer therapy effectiveness and reduce side effects.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Solid tumors exhibit areas of poor perfusion, leading to hypoxia, acidity, and nutrient deprivation.
- These tumor microenvironmental conditions contribute to resistance against radiation and chemotherapy.
- These inadequacies also present unique targets for novel therapeutic strategies.
Purpose of the Study:
- To explore the therapeutic potential of targeting the tumor microenvironment.
- To investigate the use of hypoxia-directed drugs in cancer treatment.
Main Methods:
- Analysis of solid tumors in experimental animals and human patients.
- Evaluation of drug resistance mechanisms associated with tumor hypoxia and nutrient deprivation.
- Assessment of regimens combining hypoxia-directed drugs with radiotherapy or chemotherapy.
Main Results:
- Hypoxia and nutrient deprivation in tumors induce resistance to standard cancer therapies.
- Specific drug targeting strategies can exploit these tumor microenvironmental features.
- Combining hypoxia-directed drugs with conventional treatments can enhance tumor control.
Conclusions:
- The unique conditions within solid tumors, such as hypoxia, can be therapeutically exploited.
- Hypoxia-directed drugs offer a promising approach to overcome treatment resistance.
- Integrating these agents into treatment regimens can improve the therapeutic ratio by enhancing tumor control without increasing normal tissue toxicity.